374 related articles for article (PubMed ID: 8594683)
21. Sudan mucosal leishmaniasis.
Abdalla RE; El Hadi A; Ahmed MA; El Hassan AM
Trans R Soc Trop Med Hyg; 1975; 69(5-6):443-9. PubMed ID: 1228983
[TBL] [Abstract][Full Text] [Related]
22. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
Thakur CP
Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
[TBL] [Abstract][Full Text] [Related]
24. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.
Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Saha SK; Ali N
Infect Immun; 1999 Dec; 67(12):6663-9. PubMed ID: 10569788
[TBL] [Abstract][Full Text] [Related]
25. Humoral and cellular immune responses to glucose regulated protein 78 -- a novel Leishmania donovani antigen.
Jensen AT; Ismail A; Gaafar A; El Hassan AM; Theander TG
Trop Med Int Health; 2002 May; 7(5):471-6. PubMed ID: 12000658
[TBL] [Abstract][Full Text] [Related]
26. Post kala azar dermal leishmaniasis in Sudan.
Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
[TBL] [Abstract][Full Text] [Related]
27. Post-kala-azar dermal leishmaniasis: a case report strikingly resembling lepromatous leprosy.
Ramesh V; Saxena U; Misra RS; Mukherjee A
Lepr Rev; 1991 Jun; 62(2):217-21. PubMed ID: 1651437
[TBL] [Abstract][Full Text] [Related]
28. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
Salih MAM; Fakiola M; Lyons PA; Younis BM; Musa AM; Elhassan AM; Anderson D; Syn G; Ibrahim ME; Blackwell JM; Mohamed HS
Parasite Immunol; 2017 Jun; 39(6):. PubMed ID: 28370072
[TBL] [Abstract][Full Text] [Related]
29. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
30. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
[TBL] [Abstract][Full Text] [Related]
31. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
[TBL] [Abstract][Full Text] [Related]
32. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
33. Kala-azar in a high transmission focus: an ethnic and geographic dimension.
Ibrahim ME; Lambson B; Yousif AO; Deifalla NS; Alnaiem DA; Ismail A; Yousif H; Ghalib HW; Khalil EA; Kadaro A; Barker DC; El Hassan AM
Am J Trop Med Hyg; 1999 Dec; 61(6):941-4. PubMed ID: 10674674
[TBL] [Abstract][Full Text] [Related]
34. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
[TBL] [Abstract][Full Text] [Related]
35. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
[TBL] [Abstract][Full Text] [Related]
36. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
Andrade CR; Nascimento AE; Moura PM; Andrade PP
Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
[TBL] [Abstract][Full Text] [Related]
37. Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.
el-Hassan AM; Hashim FA; Ali MS; Ghalib HW; Zijlstra EE
Trans R Soc Trop Med Hyg; 1993; 87(4):395-8. PubMed ID: 8249061
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
Mathur P; Samantaray J; Chauhan NK
Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
[TBL] [Abstract][Full Text] [Related]
39. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
Meinecke CK; Schottelius J; Oskam L; Fleischer B
Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591
[TBL] [Abstract][Full Text] [Related]
40. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
